Hypertension in Peripheral Arterial Disease

E-ISSN： 1873-4286|10|29|3615-3620

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.29, 2004-11, pp. : 3615-3620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beraprost: A Review of its Pharmacology and Therapeutic Efficacy in the Treatment of Peripheral Arterial Disease and Pulmonary Arterial Hypertension

By Melian E.B. Goa K.L.

Drugs, Vol. 62, Iss. 1, 2002-01 ,pp. : 107-133

Adis International

Access to resources Recommend Favorite

Cilostazol and peripheral arterial disease

By Pearce Lyndsay Ghosh Jonathan Counsell Andrew Serracino-Inglott Ferdinand

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2683-2690

Informa Healthcare

Access to resources Recommend Favorite

Antioxidants in Peripheral Arterial Disease

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 651-655

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging drugs in peripheral arterial disease

By Tulsyan Nirman Ouriel Kenneth Kashyap Vikram S

Expert Opinion on Emerging Drugs, Vol. 11, Iss. 1, 2006-03 ,pp. : 75-90

Informa Healthcare

Access to resources Recommend Favorite

Lipid Management and Peripheral Arterial Disease

Current Drug Targets, Vol. 8, Iss. 4, 2007-04 ,pp. : 561-570

Bentham Science Publishers

Access to resources Recommend Favorite